1. Home
  2. TEVA vs HUBB Comparison

TEVA vs HUBB Comparison

Compare TEVA & HUBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • HUBB
  • Stock Information
  • Founded
  • TEVA 1901
  • HUBB 1888
  • Country
  • TEVA Israel
  • HUBB United States
  • Employees
  • TEVA N/A
  • HUBB N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • HUBB Industrial Machinery/Components
  • Sector
  • TEVA Health Care
  • HUBB Technology
  • Exchange
  • TEVA Nasdaq
  • HUBB Nasdaq
  • Market Cap
  • TEVA 20.1B
  • HUBB 20.9B
  • IPO Year
  • TEVA N/A
  • HUBB N/A
  • Fundamental
  • Price
  • TEVA $16.97
  • HUBB $395.59
  • Analyst Decision
  • TEVA Strong Buy
  • HUBB Hold
  • Analyst Count
  • TEVA 8
  • HUBB 8
  • Target Price
  • TEVA $25.00
  • HUBB $459.25
  • AVG Volume (30 Days)
  • TEVA 11.1M
  • HUBB 552.4K
  • Earning Date
  • TEVA 07-30-2025
  • HUBB 07-29-2025
  • Dividend Yield
  • TEVA N/A
  • HUBB 1.33%
  • EPS Growth
  • TEVA N/A
  • HUBB 10.31
  • EPS
  • TEVA N/A
  • HUBB 14.79
  • Revenue
  • TEVA $16,616,000,000.00
  • HUBB $5,594,600,000.00
  • Revenue This Year
  • TEVA $5.69
  • HUBB $7.60
  • Revenue Next Year
  • TEVA N/A
  • HUBB $5.93
  • P/E Ratio
  • TEVA N/A
  • HUBB $26.74
  • Revenue Growth
  • TEVA 3.82
  • HUBB 1.97
  • 52 Week Low
  • TEVA $12.47
  • HUBB $299.43
  • 52 Week High
  • TEVA $22.80
  • HUBB $481.35
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 48.95
  • HUBB 57.51
  • Support Level
  • TEVA $16.82
  • HUBB $380.86
  • Resistance Level
  • TEVA $17.73
  • HUBB $402.37
  • Average True Range (ATR)
  • TEVA 0.55
  • HUBB 7.54
  • MACD
  • TEVA -0.13
  • HUBB -0.78
  • Stochastic Oscillator
  • TEVA 25.14
  • HUBB 75.51

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.

Share on Social Networks: